GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 NewbornsBusiness Wire • 10/08/24
GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024Business Wire • 10/03/24
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA AnalyticsInvestors Business Daily • 09/19/24
How Much Upside is Left in GENEDX HOLDINGS (WGS)? Wall Street Analysts Think 40.34%Zacks Investment Research • 08/05/24
GeneDx Holdings Corp. (WGS) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 07/30/24
GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More PatientsBusiness Wire • 07/30/24
What Makes GeneDx Holdings Corp. (WGS) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 07/18/24
All You Need to Know About GENEDX HOLDINGS (WGS) Rating Upgrade to Strong BuyZacks Investment Research • 07/12/24
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024GlobeNewsWire • 07/11/24
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal PatientsGlobeNewsWire • 06/10/24
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy PatientsGlobeNewsWire • 06/05/24
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 04/29/24
GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease DatasetGlobeNewsWire • 04/23/24
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024GlobeNewsWire • 04/04/24